Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: pH-responsiveness

January 21, 2026 Drug delivery / Pharma applications

pH-responsive magnetic cyclodextrin-liposome nanoplatforms for stabilization and targeted delivery of topotecan

Topotecan (TPT), a potent anticancer agent, suffers from rapid hydrolysis of its active lactone ring under physiological conditions, severely limiting

Continue reading

June 12, 2025 Drug delivery / Pharma applications

Magnetic Carboxymethyl-β-Cyclodextrin nanocarrier for targeted sitagliptin delivery

This study aimed to magnetize β-cyclodextrin (β-CD) to serve as a nanocarrier for sitagliptin (Sita) in targeted drug delivery applications.

Continue reading

June 25, 2024 Drug delivery / Pharma applications

Dual encapsulation and sequential release of cisplatin and vitamin E from soy polysaccharides and β-cyclodextrin bioadhesive hydrogel nanoparticles

This study applied pH-thermal dual responsive bio-adhesive chemically cross-linked hydrogel nanoparticles (HGNPs) for dual complexation and enhanced the controlled release

Continue reading

July 5, 2021 CD derivatives / Drug delivery / Pharma applications / Supramolecular systems

Hyperbranched polymers functionalized β-cyclodextrin

Wan et al. (2021) published on the synthesis and potential utilization of β-CD modified with hyperbranced polyglycerol polymer and decorated

Continue reading

Recent Posts

  • Comparison of the siRNA and mRNA Carrying Capacity of Quaternary Ammonium β-Cyclodextrin Polymer and Polyethylenimine
  • Call for Chapters: Cyclodextrins in Phytomedicine
  • Poly-CD-PEG-camptothecin Combined with Olaparib  in People With Relapsed/​Refractory Small Cell Lung Cancer (Clinical trial)
  • Alkali Metal Adduct Formation in Cyclic Ion Mobility-Mass Spectrometry of O-Methylated Cyclodextrin Isomers
  • Doxycycline release from cyclodextrin oligomer-containing collagen gels

Tags

alpha-CD Alzheimer disease atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (70)
  • CD as API (347)
  • CD derivatives (415)
  • Cosmetics and toilettry (52)
  • Diagnosis (12)
  • Drug delivery (797)
  • E-ducation (63)
  • Environmental (135)
  • Events (234)
  • Food (225)
  • Gene delivery (21)
  • Household products (4)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (43)
  • Non-pharma applications (403)
  • Other industrial use (107)
  • Pharma applications (1,190)
  • Supramolecular systems (40)
  • Uncategorized (152)

Top Posts

  • Call for Chapters: Cyclodextrins in Phytomedicine
  • Poly-CD-PEG-camptothecin Combined with Olaparib  in People With Relapsed/​Refractory Small Cell Lung Cancer (Clinical trial)
  • Comparison of the siRNA and mRNA Carrying Capacity of Quaternary Ammonium β-Cyclodextrin Polymer and Polyethylenimine
  • New FDA approved medicinal product containing Betadex sulfobutylether sodium: VYKOURA
  • GRAS status of CD derivatives
  • Cyclarity Unveils First-Ever Clinical Data Demonstrating Excretion of Oxidized Cholesterol, at American Heart Association Vascular Discovery Scientific Sessions
  • Citric acid cross-linked β-cyclodextrins: A review of preparation and environmental/biomedical application
  • A Cyclodextrin Surprise in a Japanese Supplement
  • HPBCD in pet care: shampoo and deodorising spray for dogs
  • Alkali Metal Adduct Formation in Cyclic Ion Mobility-Mass Spectrometry of O-Methylated Cyclodextrin Isomers

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,474 other subscribers

Loading Comments...